BDBM620855 (3S,4S) or (3R,4R) 4-(4-(2-((5- chloro-1-(2,2-(R) or (S) difluorocyclopropyl)-1H- pyrazol-4-yl)amino)-6- methylquinazolin-7-yl)piperazin- 1-yl)-4-methyltetrahydrofuran-3- ol::US20230303540, Example Ex-5.5

SMILES Cc1cc2cnc(Nc3cnn(C4CC4(F)F)c3Cl)nc2cc1N1CCN(CC1)C1(C)COCC1O

InChI Key InChIKey=QPTCSDATEASTCL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 620855   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620855((3S,4S) or (3R,4R) 4-(4-(2-((5- chloro-1-(2,2-(R) ...)
Affinity DataIC50: 0.420nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent